Pharmacokinetic optimisation of the treatment of septic arthritis

Clinical Pharmacokinetics

Volumn 31, Issue 2, 1996, Pages 156-163

  Hamed, Kamal A ^a   Tam, Janice Y ^a   Prober, Charles G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTHROSCOPY; ASPIRATION; BACTERIAL ARTHRITIS; DRUG CHOICE; DRUG MONITORING; DRUG SYNOVIAL FLUID LEVEL; EARLY DIAGNOSIS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029945298     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199631020-00006     Document Type: Review

References (32)

1. Prober CG. Current antibiotic therapy of community-acquired bacterial infections in hospitalized children: bone and joint infections. Pediatr Infect Dis J 1992; 11: 156-9
2. Wilber RB. Beta-lactam therapy of osteomyelitis and septic arthritis. Scand J Infect Dis 1984; 42: 155-68
3. Brause BD. Infections associated with prosthetic joints. Clin Rheum Dis 1986; 12: 523-36
4. Smith JW, Piercy EA. Infectious arthritis. Clin Infect Dis J 1995; 20: 225-31
5. Dorff GJ, Ziokowski JS, Rytel MW. Detection by counterimmunoelectrophoresis of pneumococcal antigen in synovial fluid from septic arthritis. Arthritis Rheum 1975; 18: 613-5
6. Tuazon CU. Teichoic acid antibodies in osteomyelitis and septic arthritis caused by Staphylococcus aureus. J Bone Joint Surg 1982; 64A: 762-5
7. Nelson JD. Antibiotic concentrations in septic joint effusions. N Engl J Med 1971; 284: 349-53
8. Parker RH, Schmid FR. Antibacterial activity of synovial fluid during therapy of septic arthritis. Arthritis Rheum 1971; 14: 96-104
9. Tetzlaff TR, Howard JB, McCracken GH, et al. Antibiotic concentrations in pus and bone of children with osteomyclitis. J Pediatr 1978; 92: 135-40
10. Nelson JD, Howard JB, Shelton S. Oral antibiotic therapy for skeletal infections of children. J Pediatr 1978; 92: 131-4
11. Howell A, Sutherland R, Rolinson GN. Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid. Clin Pharmacol Ther 1972; 13: 724-32
12. Viek P. Concentration of sodium nafcillin in pathological synovial fluid. Antimicrob Agents Chemother 1962; 379-83
13. Baciocco EA, Iles RL. Ampicillin and kanamycin concentrations in joint fluid. Clin Pharmacol Ther 1971; 12: 858-63
14. Schurman DJ, Hirshman HP, Kajiyama G, et al. Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg 1978; 60-A: 359-62
15. Valencia-Chinas A, Galindo-Hernandez F, Reyes-Sanchez J, et al. Concentrations of cefadroxil in osteoarticular tissues [abstract no. 338]. Abstracts of the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy; American Society for Microbiology; 1979: Washington, DC.
16. Vainiopää S, Wilppula E, Lalla M, et al. Cefamandole and isoxazolyl penicillins in antibiotic prophylaxis of patients undergoing total hip or knee-joint arthroplasty. Arch Orthop Trauma Surg 1988; 107: 228-30
17. Harle A, Ritzerfeld W, Kluppelberg FH. Cefotaxime levels in synovial fluid following intravenous administration. Z Orthop Ihre Grenzgeb 1988; 126: 425-30
18. Morgan JR, Paull A, O'Sullivan M, et al. The penetration of ceftriaxone into synovial fluid of the inflamed joint. J Antimicrob Chemother 1985; 16: 367-71
19. Somekh E, Heifets L, Tanai A, et al. Penetration of cefixime into synovial fluid [abstract A56]. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1995 Sep 17; Washington, DC: 11
20. MacLeod CM, Bartley EA, Galante JO, et al. Aztreonam penetration into synovial fluid and bone. Antimicrob Agents Chemother 1986; 29: 710-2
21. Bosseray A, Leclercq P, Manquat G, et al. Penetration of ciprofloxacin into synovial fluid after oral dosing. J Antimicrob Chemother 1992; 30: 874-5
22. Dee TH, Kozin F. Gentamicin and tobrumycin penetration into synovial fluid. Antimicrob Agents Chemother 1977; 12: 548-9
23. Geraci JE, Heilman ER, Nichols DR, et al. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proc Staff Meetings Mayo Clin 1956; 31: 564-82
24. Gerding DN, Peterson LR, Hughes CE, et al. Extravascular antimicrobial distribution and the respective blood-concentrations in humans. In: Lorian V, editor. Antibiotics in laboratory medicine. 3rd ed. Baltimore: Williams & Wilkins, 1991
25. Drutz DJ, Schaffner W, Hillman JW, et al. The penetration of penicillin and other antimicrobials into joint fluid. J Bone Joint Surg 1967; 49-A: 1415-21
26. Hedström SÅ, Lindgren L, Nilsson-Ehle I. Cefuroxime in acute septic arthritis. Scand J Infect Dis 1984; 16: 79-82
27. Parker RH, Birbara C, Schmid FR. Passage of nafcillin and ampicillin into synovial fluid. In: Jeljaszewicz J, editor. Staphylococci and staphylococcal diseases. New York: Gustav Fischer Verlag, 1976: 1115-23
28. Sutherland R, Croydon EA, Rolinson GN. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. BMJ 1970; 4: 455-60
29. Black J, Hunt TL, Godley PJ, et al. Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis. J Infect Dis 1987; 155: 968-72
30. Kolyvas E, Ahronheim G, Marks MI, et al. Oral antibiotic therapy of skeletal infections in children. Pediatrics 1980; 65: 867-71
31. Nelson JD, Bucholz RW, Kusmiesz H, et al. Benefits and risks of sequential parenteral-oral cephalosporin therapy for suppurative bone and joint infections. J Pediatr Orthop 1982; 2: 255-62
32. Prober CG. Oral antibiotic therapy for bone and joint infections. Pediatr Infect Dis J 1982; 1: 8-10